Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Aug;89(8):855-61.
doi: 10.1111/j.1349-7006.1998.tb00640.x.

Differential expression of DNA topoisomerase II alpha and II beta genes between small cell and non-small cell lung cancer

E Syahruddin  1 , T Oguri, T Takahashi, T Isobe, Y Fujiwara, M Yamakido
Affiliations

Differential expression of DNA topoisomerase II alpha and II beta genes between small cell and non-small cell lung cancer

E Syahruddin et al. Jpn J Cancer Res. 1998 Aug.

Abstract

DNA topoisomerase II (Topo II) inhibitors are widely used in lung cancer chemotherapy, but small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) show different sensitivity to them. In this study, we examined the gene expression levels of both isoforms of Topo II (II alpha and II beta) in lung cancer specimens to investigate the differential expression between SCLC and NSCLC. The expression levels of the Topo II alpha and Topo II beta genes were assessed in 80 autopsy samples (40 primary tumors and 40 corresponding normal lung tissues) by using the reverse transcription polymerase chain reaction. We found that the expression levels of the Topo II alpha gene in tumors were significantly higher than those in normal lung tissues, and that those in SCLC were significantly higher than those in NSCLC. There were no significant differences in Topo II beta gene expression between tumors and normal lung tissues and between SCLC and NSCLC. Further-more, correlation analysis revealed that Topo II alpha expression was correlated with Topo II beta expression in both tumor and normal lung tissues. These results indicate that a difference exists in the regulation of the Topo II gene between lung tumors and normal lung tissues. Our finding of differential expression of Topo II alpha between SCLC and NSCLC also suggests that the Topo II alpha expression level is associated with sensitivity to Topo II inhibitors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. ) Wang , J. C.DNA topoisomerases . Annu. Rev. Biochem. , 65 , 635 – 692 ( 1996. ). - PubMed
    1. ) Woessner , R. D. , Mattern , M. R. , Mirabelli , C. K. , Johnson , R. K. and Darke , F. H.Proliferation‐ and cell cycle‐dependent differences in expression of the 170 kilo‐dalton and 180 kilodalton forms of topoisomerase II in NIH‐3T3 cells . Cell Growth Differ. , 2 , 209 – 214 ( 1991. ). - PubMed
    1. ) Hwang , J. and Hwong , C.‐L.Cellular regulation of mammalian DNA topoisomerases . Adv. Pharmacol. , 29A , 167 – 189 ( 1994. ). - PubMed
    1. ) Meyer , K. N. , Kjeldsen , E. , Straub , T. , Knudsen , B. R. , Hickson I. D. , Kikuchi , A. , Kreipe , H. and Boege , F.Cell cycle‐coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities . J. Cell Biol. , 136 , 775 – 788 ( 1997. ). - PMC - PubMed
    1. ) Doyle , L. A. , Ross , D. D. , Ordonez , J. V. , Yang , W. , Gao , Y. , Tong , Y. , Belani , C. B. and Gutheil , J. C.An etopo‐side‐resistant lung cancer subline overexpresses the multi‐drug resistance‐associated protein . Br. J. Cancer , 72 , 535 – 542 ( 1995. ). - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources